3,4-dihydroxyphenylacetic acid has been researched along with Inflammation in 9 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral treatment with chrysin (10 mg/kg, 28 days), culminated with the prevention of these alterations occasioned by 6-OHDA." | 5.48 | Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins. ( Antunes, MS; Boeira, SP; Goes, ATR; Jesse, CR; Lobo Ladd, AAB; Lobo Ladd, FV; Luchese, C; Paroul, N, 2018) |
| "Oral treatment with chrysin (10 mg/kg, 28 days), culminated with the prevention of these alterations occasioned by 6-OHDA." | 1.48 | Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins. ( Antunes, MS; Boeira, SP; Goes, ATR; Jesse, CR; Lobo Ladd, AAB; Lobo Ladd, FV; Luchese, C; Paroul, N, 2018) |
| "The present research examined morphine dose-response effects on both the formalin test and on CNS monoamine (MA) levels and the metabolites dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) in hypoalgesic (76) and hyperalgesic (SN) strains of domestic fowl." | 1.28 | Central monoaminergic changes induced by morphine in hypoalgesic and hyperalgesic strains of domestic fowl. ( Hoganson, DA; Hughes, RA; Sufka, KJ, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Moreno Uclés, R | 1 |
| González-Sarrías, A | 1 |
| Espín, JC | 1 |
| Tomás-Barberán, FA | 1 |
| Janes, M | 1 |
| Cheng, H | 1 |
| Finley, J | 1 |
| Greenway, F | 1 |
| Losso, JN | 1 |
| Goes, ATR | 1 |
| Jesse, CR | 1 |
| Antunes, MS | 1 |
| Lobo Ladd, FV | 1 |
| Lobo Ladd, AAB | 1 |
| Luchese, C | 1 |
| Paroul, N | 1 |
| Boeira, SP | 1 |
| Ren, M | 1 |
| Guo, Y | 1 |
| Wei, X | 1 |
| Yan, S | 1 |
| Qin, Y | 1 |
| Zhang, X | 1 |
| Jiang, F | 1 |
| Lou, H | 1 |
| Chen, X | 1 |
| Zhou, C | 1 |
| Guo, J | 1 |
| Sun, K | 1 |
| Zhao, N | 1 |
| Yang, J | 1 |
| Sun, Y | 1 |
| Liu, X | 1 |
| Hibi, T | 1 |
| Liu, Z | 1 |
| Han, J | 1 |
| Tsai, SJ | 1 |
| Chao, CY | 1 |
| Yin, MC | 1 |
| Thakur, P | 1 |
| Nehru, B | 1 |
| Vizuete, ML | 1 |
| Merino, M | 1 |
| Venero, JL | 1 |
| Santiago, M | 1 |
| Cano, J | 1 |
| Machado, A | 1 |
| Sufka, KJ | 1 |
| Hoganson, DA | 1 |
| Hughes, RA | 1 |
9 other studies available for 3,4-dihydroxyphenylacetic acid and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Effects of red raspberry polyphenols and metabolites on the biomarkers of inflammation and insulin resistance in type 2 diabetes: a pilot study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biomarkers; Diabetes Mellitus, Type 2; Health Promotion; Humans; Inf | 2022 |
Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Dopamine; Flavonoids; Gene Expression Regulatio | 2018 |
TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adenoviridae; Animals; | 2018 |
Effects of dihydroxylphenyl lactic acid on inflammatory responses in spinal cord injury.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents; Disease Models, Animal; I-kappa B | 2011 |
Preventive and therapeutic effects of caffeic acid against inflammatory injury in striatum of MPTP-treated mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Brain-Derived Neurotrophic Factor; Caffeic Aci | 2011 |
Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Brain; Catalase; Cy | 2013 |
Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Choline O-Acetyltransferase; Corpus Striatum; D | 2000 |
Central monoaminergic changes induced by morphine in hypoalgesic and hyperalgesic strains of domestic fowl.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain Chemistry; Chickens; Chromatogra | 1992 |